Parthenolide-alkyne pulldown studies to identify molecular targets in glioblastoma and acute myeloid leukemia cells

被引：0

作者：

Jones, Katherine ^{[1
]}

Widen, John ^{[2
]}

Skopec, Hannah ^{[1
]}

Wang, Dan ^{[2
]}

Hexum, Joseph ^{[2
]}

Rathe, Susan ^{[3
]}

Largaespada, David ^{[3
,4
,5
]}

Harki, Daniel ^{[1
,5
,6
]}

机构：

[1] Univ Minnesota, Chem, St Paul, MN 55108 USA

[2] Univ Minnesota, Med Chem, Minneapolis, MN USA

[3] Univ Minnesota, Pediat Cell Biol & Dev, Minneapolis, MN USA

[4] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN USA

[5] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA

[6] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 258卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

218-BIOL

引用

页数：2

共 50 条

[31] Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells
Petrov, Ivan
Suntsova, Maria
Mutorova, Olga
Sorokin, Maxim
Garazha, Andrew
Ilnitskaya, Elena
Spirin, Pavel
Larin, Sergey
Zhavoronkov, Alex
Kovalchuk, Olga
Prassolov, Vladimir
Roumiantsev, Alexander
Buzdin, Anton
AGING-US, 2016, 8 (11): : 2936 - 2947
[32] Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia
Prommersberger, Sabrina
Jetani, Hardikkumar
Danhof, Sophia
Monjezi, Razieh
Nerreter, Thomas
Beckmann, Julia
Einsele, Herrmann
Hudecek, Michael
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2018, 66 (02) : 37 - 38
[33] Pathogenesis of Acute Myeloid Leukemia: In Vitro Studies Using Primary Human Cells
Abdul-Nabi, Anmaar
Yassin, Enas R.
Takeda, Akiko
Yaseen, Nabeel R.
BLOOD, 2008, 112 (11) : 790 - 790
[34] Acute myeloid leukemia in children and adolescents: identification of new molecular targets brings promise of new therapies
Kolb, E. Anders
Meshinchi, Soheil
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 507 - 513
[35] Novel Therapeutic Combining CS055 with Chiglitazar Targets Leukemia Stem and Progenitor Cells in Acute Myeloid Leukemia
Zhou, Hui
Qin, Dongmei
Xie, Chendi
Zhou, Jie
Li, Wenjuan
Zhong, Mengya
Jiang, Yuelong
Deng, Manman
Zhao, Haijun
Zhou, Yong
Lai, Qian
Fang, Zhihong
Luo, Yiming
Xu, Bing
Zha, Jie
BLOOD, 2022, 140 : 11731 - 11731
[36] In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies
Björn Hackanson
Christian Robbel
Pierre Wijermans
Michael Lübbert
Annals of Hematology, 2005, 84 : 32 - 38
[37] In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia:: review of cytogenetic and molecular studies
Hackanson, B
Robbel, C
Wijermans, P
Lübbert, M
ANNALS OF HEMATOLOGY, 2005, 84 (Suppl 1) : 32 - 38
[38] Human pluripotent stem cells identify molecular targets of trisomy 12 in chronic lymphocytic leukemia patients
Reid, Jennifer C.
Golubeva, Diana
Boyd, Allison L.
Hollands, Cameron G.
Henly, Charisa
Orlando, Luca
Leber, Andrew
Hebert, Josee
Morabito, Fortunato
Cutrona, Giovanna
Agnelli, Luca
Gentile, Massimo
Ferrarini, Manlio
Neri, Antonino
Leber, Brian
Bhatia, Mickie
CELL REPORTS, 2021, 34 (11):
[39] Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT) Activity Selectively Targets Human Acute Myeloid Leukemia Stem Cells
Subedi, Amit
Liu, Qiang
Sharon, David
Xu, Changjiang
Voisin, Veronique
Bader, Gary D.
Wang, Jean
Chan, Steven M.
BLOOD, 2018, 132
[40] Dual IKZF2 and CK1a degrader targets acute myeloid leukemia cells
Park, Sun-Mi
Miyamoto, David K.
Han, Grace Y. Q.
Chan, Mandy
Curnutt, Nicole M.
Tran, Nathan L.
Velleca, Anthony
Kim, Jun Hyun
Schurer, Alexandra
Chang, Kathryn
Xu, Wenqing
Kharas, Michael G.
Woo, Christina M.
CANCER CELL, 2023, 41 (04) : 726 - +

← 1 2 3 4 5 →